• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.2005-2018 年美国人类免疫缺陷病毒感染者进入护理时和开始抗逆转录病毒治疗时的 CD4 计数。
Clin Infect Dis. 2021 Oct 5;73(7):e2334-e2337. doi: 10.1093/cid/ciaa1904.
2
Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study.2004-2018 年美国按年龄划分的进入 HIV 护理和抗逆转录病毒治疗处方时的观察 CD4 计数：一项队列研究。
Lancet HIV. 2022 Mar;9 Suppl 1:S2. doi: 10.1016/S2352-3018(22)00067-4.
3
[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].[西班牙艾滋病研究与治疗学会（Gesida）和西班牙国家艾滋病防治计划秘书处（SPNS）关于人类免疫缺陷病毒感染成人联合抗逆转录病毒治疗的共识文件（2012年1月）]
Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Epub 2012 May 23.
4
Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.抗逆转录病毒治疗时机对人类免疫缺陷病毒 1 感染个体免疫状态正常化潜力的影响。
JAMA Intern Med. 2015 Jan;175(1):88-99. doi: 10.1001/jamainternmed.2014.4010.
5
CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.CD4细胞计数：抗逆转录病毒治疗资格的递减值。
Clin Infect Dis. 2016 Apr 15;62(8):1022-8. doi: 10.1093/cid/civ1224. Epub 2016 Jan 29.
6
An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.体重指数最佳范围与接受抗逆转录病毒治疗的 HIV 感染成年人免疫重建改善相关。
Clin Infect Dis. 2011 Nov;53(9):952-60. doi: 10.1093/cid/cir606. Epub 2011 Sep 26.
7
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.立即启动抗逆转录病毒治疗对 CD4 细胞计数超过 500 个/μL 的 HIV 阳性人群中严重细菌感染风险的影响：一项随机对照试验的次要结局结果。
Lancet HIV. 2017 Mar;4(3):e105-e112. doi: 10.1016/S2352-3018(16)30216-8. Epub 2017 Jan 5.
8
Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.卢旺达全国队列研究：HIV 阳性成年患者在进行 HIV 护理衔接和开始抗逆转录病毒治疗时的基线 CD4 细胞计数对死亡率的影响。
Lancet HIV. 2015 Sep;2(9):e376-84. doi: 10.1016/S2352-3018(15)00112-5. Epub 2015 Aug 4.
9
Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.南非夸祖鲁 - 纳塔尔省农村地区CD4细胞计数>500个细胞/μL的成年人开始接受抗逆转录病毒治疗的时间。
HIV Med. 2015 Sep;16(8):512-8. doi: 10.1111/hiv.12255. Epub 2015 May 11.
10
Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.卢旺达国家抗逆转录病毒治疗指南变更后，抗逆转录病毒治疗起始时CD4+细胞计数的趋势及其相关因素。
AIDS. 2015 Jan 2;29(1):67-76. doi: 10.1097/QAD.0000000000000520.

引用本文的文献

1
A Blast From the Past: Toxoplasmic Encephalitis As the Initial Presentation of HIV/AIDS.来自过去的警示：弓形虫性脑炎作为HIV/AIDS的首发表现
Cureus. 2024 Apr 21;16(4):e58693. doi: 10.7759/cureus.58693. eCollection 2024 Apr.
2
Leveraging CD4 Cell Count at Entry Into Care to Monitor Success of Human Immunodeficiency Virus Prevention, Treatment, and Public Health Programming in the Greater St Louis Area Between 2017 and 2020.利用护理初诊时的CD4细胞计数监测2017年至2020年大圣路易斯地区人类免疫缺陷病毒预防、治疗及公共卫生项目的成效
Open Forum Infect Dis. 2023 Sep 18;10(10):ofad477. doi: 10.1093/ofid/ofad477. eCollection 2023 Oct.
3
Temporal Trends of Clinical Characteristics and Treatments in People Living with HIV at the Initiation of Antiretroviral Therapy - Beijing Municipality, China, 2010-2020.2010 - 2020年中国北京市接受抗逆转录病毒治疗初始阶段HIV感染者的临床特征及治疗的时间趋势
China CDC Wkly. 2023 Feb 10;5(6):131-136. doi: 10.46234/ccdcw2023.024.
4
Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population.成人在普遍早期治疗下进入艾滋病毒护理的五年死亡率与美国一般人群相比。
Clin Infect Dis. 2022 Sep 14;75(5):867-874. doi: 10.1093/cid/ciab1030.
5
Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study.接受艾滋病病毒护理的人与美国普通人群的死亡率比较：一项观察性研究。
Ann Intern Med. 2021 Sep;174(9):1197-1206. doi: 10.7326/M21-0065. Epub 2021 Jul 6.
6
Timeliness of antiretroviral therapy initiation in the era before universal treatment.抗逆转录病毒治疗在普遍治疗之前时代的及时性。
Sci Rep. 2021 May 18;11(1):10508. doi: 10.1038/s41598-021-90043-7.
7
Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B.每 2 周使用罗匹尼罗干扰素 alfa-2b 作为新型聚乙二醇干扰素治疗慢性乙型肝炎患者。
Hepatol Int. 2020 Dec;14(6):997-1008. doi: 10.1007/s12072-020-10098-y. Epub 2020 Oct 24.

本文引用的文献

1
Implementation of "Treat-all" at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey.全球 IeDEA 联盟成人艾滋病毒护理和治疗点“治疗所有”的实施情况：来自地点评估调查的结果。
J Int AIDS Soc. 2019 Jul;22(7):e25331. doi: 10.1002/jia2.25331.
2
Mind the gap: observation windows to define periods of event ascertainment as a quality control method for longitudinal electronic health record data.注意差距：观察窗口作为纵向电子健康记录数据质量控制方法，用于定义事件确定的时间段。
Ann Epidemiol. 2019 May;33:54-63. doi: 10.1016/j.annepidem.2019.01.015. Epub 2019 Mar 4.
3
Ending the HIV Epidemic: A Plan for the United States.终结美国的艾滋病流行：一项计划
JAMA. 2019 Mar 5;321(9):844-845. doi: 10.1001/jama.2019.1343.
4
Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and Hispanic persons living with HIV in the United States: a qualitative exploration.批判种族理论作为理解美国非裔/黑人及西班牙裔艾滋病毒感染者在艾滋病毒护理连续过程中参与度低的一种工具：一项定性探索。
Int J Equity Health. 2017 Mar 24;16(1):54. doi: 10.1186/s12939-017-0549-3.
5
Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color.HIV 阳性有色人种女性进行检测、治疗进入和参与护理的障碍和促进因素。
AIDS Patient Care STDS. 2013 Jul;27(7):398-407. doi: 10.1089/apc.2012.0435.
6
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.2000 年至 2008 年美国艾滋病毒感染者抗逆转录病毒治疗使用、HIV RNA 血浆病毒载量和 CD4 淋巴细胞计数的趋势。
Ann Intern Med. 2012 Sep 4;157(5):325-35. doi: 10.7326/0003-4819-157-5-201209040-00005.
7
Challenges and successes in linking HIV-infected women to care in the United States.在美国，将感染艾滋病毒的女性与护理联系起来的挑战和成功。
Clin Infect Dis. 2011 Jan 15;52 Suppl 2:S231-7. doi: 10.1093/cid/ciq047.
8
Effect of early versus deferred antiretroviral therapy for HIV on survival.早期与延迟抗逆转录病毒疗法对HIV感染者生存的影响。
N Engl J Med. 2009 Apr 30;360(18):1815-26. doi: 10.1056/NEJMoa0807252. Epub 2009 Apr 1.
9
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).队列简介：北美艾滋病队列研究与设计协作组（NA-ACCORD）
Int J Epidemiol. 2007 Apr;36(2):294-301. doi: 10.1093/ije/dyl286. Epub 2007 Jan 8.
10
The Joint United Nations Programme on HIV / AIDS (UNAIDS). Project update.联合国艾滋病规划署（UNAIDS）。项目最新情况。
Pac AIDS Alert Bull. 1999(18):15-6.

2005-2018 年美国人类免疫缺陷病毒感染者进入护理时和开始抗逆转录病毒治疗时的 CD4 计数。

CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.

机构信息

Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA.

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

Clin Infect Dis. 2021 Oct 5;73(7):e2334-e2337. doi: 10.1093/cid/ciaa1904.

DOI:10.1093/cid/ciaa1904
PMID:33383586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8492212/
Abstract

From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/μL, and CD4 count at ART prescription increased from 160 to 364 cells/μL.

摘要

从 2005 年到 2018 年，在进入治疗的 32013 名艾滋病毒感染者中，抗逆转录病毒治疗（ART）处方的中位时间从 69 天降至 6 天，进入治疗时的 CD4 计数从 300 个细胞/μL 增加到 362 个细胞/μL，ART 处方时的 CD4 计数从 160 个细胞/μL 增加到 364 个细胞/μL。